Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern

COVID-19 vaccine design and vaccination rollout need to take into account a detailed understanding of antibody durability and cross-neutralizing potential against SARS-CoV-2 and emerging variants of concern (VOCs). Analyses of convalescent sera provide unique insights into antibody longevity and cro...

Descripción completa

Detalles Bibliográficos
Autores principales: Dupont, Liane, Snell, Luke B., Graham, Carl, Seow, Jeffrey, Merrick, Blair, Lechmere, Thomas, Maguire, Thomas J. A., Hallett, Sadie R., Pickering, Suzanne, Charalampous, Themoula, Alcolea-Medina, Adela, Huettner, Isabella, Jimenez-Guardeño, Jose M., Acors, Sam, Almeida, Nathalia, Cox, Daniel, Dickenson, Ruth E., Galao, Rui Pedro, Kouphou, Neophytos, Lista, Marie Jose, Ortega-Prieto, Ana Maria, Wilson, Harry, Winstone, Helena, Fairhead, Cassandra, Su, Jia Zhe, Nebbia, Gaia, Batra, Rahul, Neil, Stuart, Shankar-Hari, Manu, Edgeworth, Jonathan D., Malim, Michael H., Doores, Katie J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556155/
https://www.ncbi.nlm.nih.gov/pubmed/34654917
http://dx.doi.org/10.1038/s41564-021-00974-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556155/
https://www.ncbi.nlm.nih.gov/pubmed/34654917
http://dx.doi.org/10.1038/s41564-021-00974-0

Ejemplares similares